|
Cefaseptin
|
750 mg
|
V/DCP/15/0051
|
Vetoquinol S.A., Francija
|
QJ01DB01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Cefalexin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
21-Sep-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 24092020LI (24-Sep-2020)
|
| Labelling text: |
[DOCX] 24092020M (24-Sep-2020)
|
| Summary of product characteristics: |
[DOCX] 24092020ZA (24-Sep-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0051-01 |
750 mg |
1 |
Al/Al blisteris, 6 tablete |
-
|
| V/DCP/15/0051-02 |
750 mg |
2 |
Al/Al blisteris, 6 tablete |
-
|
| V/DCP/15/0051-03 |
750 mg |
12 |
Al/Al blisteris, 6 tablete |
-
|
| V/DCP/15/0051-04 |
750 mg |
25 |
Al/Al blisteris, 6 tablete |
-
|
|
|
Cefaseptin
|
75 mg
|
V/DCP/15/0049
|
Vetoquinol S.A., Francija
|
QJ01DB01
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Cefalexin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
21-Sep-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 24092020LI (24-Sep-2020)
|
| Labelling text: |
[DOCX] 24092020M (24-Sep-2020)
|
| Summary of product characteristics: |
[DOCX] 24092020ZA (24-Sep-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0049-01 |
75 mg |
1 |
Al/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0049-02 |
75 mg |
10 |
Al/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0049-03 |
75 mg |
25 |
Al/Al blisteris, 10 tablete |
-
|
|
|
Cefaseptin
|
300 mg
|
V/DCP/15/0050
|
Vetoquinol S.A., Francija
|
QJ01DB01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Cefalexin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Vetoquinol S.A., Francija
|
| Date of authorisation/renewal: |
21-Sep-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOCX] 24092020LI (24-Sep-2020)
|
| Labelling text: |
[DOCX] 24092020M (24-Sep-2020)
|
| Summary of product characteristics: |
[DOCX] 24092020ZA (24-Sep-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0050-01 |
300 mg |
1 |
Al/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0050-02 |
300 mg |
10 |
Al/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0050-03 |
300 mg |
25 |
Al/Al blisteris, 10 tablete |
-
|
|